More on ARCT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-208.8% Growth)
- Ratings (6.2 Score)
- Holders
- Dividends (12.9% Yield)

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arcturus Therapeutics (NQ:ARCT)
Delayed: 5.53 --0 (-0%)
Prev. Close $5.53  
Open$5.53 
52 Wk High$13.09 
52 Wk Low$5.54 
Day High$5.53 
Day Low$5.53 
P/E N/A  
EPS$-0.38 
Volume101 

Friends, Peers and Foes (?): ALNY, DNLI, OTLC SRPT (more...)

Jul 20, 2026 04:01 PM Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Jul 2, 2026 07:06 AM Form 8-K Arcturus Therapeutics For: Jun 26
Jul 2, 2026 07:00 AM Arcturus and Thermo Fisher partner on cystic fibrosis mRNA therapy
Jul 2, 2026 07:00 AM Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
Jul 2, 2026 05:37 AM Freedom Broker Starts Arcturus Therapeutics (ARCT) at Buy
Jun 15, 2026 05:02 PM Form 4 Arcturus Therapeutics For: Jun 05 Filed by: HOLMES EDWARD W
Jun 15, 2026 05:02 PM Form 4 Arcturus Therapeutics For: Jun 05 Filed by: FARRELL PETER C
Jun 15, 2026 05:02 PM Form 4 Arcturus Therapeutics For: Jun 05 Filed by: BARLOW JAMES F
Jun 15, 2026 05:01 PM Form 4 Arcturus Therapeutics For: Jun 05 Filed by: Markels John
Jun 15, 2026 05:01 PM Form 4 Arcturus Therapeutics For: Jun 05 Filed by: Slaoui Moncef
View All Articles

Entities mentioned with ARCT

View All Entities